Pfizer Seeks Clearance; Signs of Early U.S. Spread: Virus Update
5 years ago 1 min read
Pfizer Inc. and partner BioNTech SE sought regulatory clearance for their vaccine in Europe, putting the shot on track for a potential approval there before the end of the year.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push